Andrade Robert's Form 4 filing
Fennec Pharmaceuticals Inc. (FENC) · filed Jun 30, 2023
- Accession no.
- 0001415889-23-010459
- Filed
- Jun 30, 2023
- Trade date
- Jun 28-30, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $223.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Andrade RobertCIK 0001468308 | Officer (CHIEF FINANCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2023 | Common shares | SSaleDisposed | −10,000 | $8.99 | −$89,900 | 139,721 | Direct | |
| Jun 29, 2023 | Common shares | SSaleDisposed | −7,500 | $8.97 | −$67,275 | 132,221 | Direct | |
| Jun 30, 2023 | Common shares | SSaleDisposed | −7,500 | $8.82 | −$66,150 | 124,721 | Direct | |
| Jun 30, 2023 | Common shares | MOption exerciseAcquired | +25,000 | $2.45 | +$61,250 | 149,721 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2023 | Options | MOption exerciseDisposed | −25,000 | $2.45 | −$61,250 | 605,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.